Zimmer’s Rosa robot, acquired in 2016, is cleared for Total Knee surgeries in the US

Zimmer Biomet Receives FDA Clearance for ROSA® Knee System for Robotically-Assisted Surgeries (press release)
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the ROSA® Knee System for robotically-assisted total knee replacement surgeries. ROSA Knee features 3D pre-operative planning tools and real-time, intraoperative data on soft-tissue and bone anatomy designed to improve bone cut accuracy and range of motion gap analysis to potentially improve flexion and resto...